IDELVION albutrepenonacog alfa 3500 IU powder (and diluent) for injection

Land: Australien

Sprache: Englisch

Quelle: Department of Health (Therapeutic Goods Administration)

Wirkstoff:

Factor IX, Quantity: 3500 IU

Verfügbar ab:

CSL Behring Australia Pty Ltd

Darreichungsform:

Solution

Zusammensetzung:

Excipient Ingredients:

Verabreichungsweg:

Intravenous

Einheiten im Paket:

3500 IU

Verschreibungstyp:

Not scheduled. Not considered by committee

Anwendungsgebiete:

IDELVION is indicated in all patients with haemophilia B for:,? Routine prophylaxis to prevent or reduce the frequency of bleeding episodes,? Control and prevention of bleeding episodes,? Control and prevention of bleeding in the perioperative setting.

Produktbesonderheiten:

Visual Identification: Clear solution; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 3 Years; Container Temperature: Store between 2 - 25 degrees celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Berechtigungsstatus:

Registered

Berechtigungsdatum:

2020-11-19